<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01097525</url>
  </required_header>
  <id_info>
    <org_study_id>20481</org_study_id>
    <nct_id>NCT01097525</nct_id>
  </id_info>
  <brief_title>Optical Quality, Threshold Target Identification, and Military Target Task Performance After Advanced Keratorefractive Surgery</brief_title>
  <official_title>Optical Quality, Threshold Target Identification, and Military Target Task Performance After Advanced Keratorefractive Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fort Belvoir Community Hospital</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Walter Reed National Military Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </collaborator>
    <collaborator>
      <agency>US Army Night Vision and Electronic Sensors Directorate</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Fort Belvoir Community Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effect of two types of wavefront modalities (WFG vs. WFO) and two types of&#xD;
      refractive surgery (PRK vs. LASIK) on visual and military task performance after laser&#xD;
      refractive surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2010</start_date>
  <completion_date type="Actual">October 2014</completion_date>
  <primary_completion_date type="Actual">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>visual outcomes</measure>
    <time_frame>12 months postoperatively</time_frame>
    <description>Visual outcomes will be measured in terms of:&#xD;
number of eyes achieving uncorrected visual acuity (UDVA) 20/20 or better.&#xD;
number of eyes maintaining one Snellen line of corrected distance visual acuity (CDVA).&#xD;
number of eyes within 0.50 diopter of manifest spherical equivalent.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>objective image quality</measure>
    <time_frame>12 months postoperatively</time_frame>
    <description>as measured by wavefront aberrometry</description>
  </primary_outcome>
  <primary_outcome>
    <measure>military task performance</measure>
    <time_frame>6 months postoperatively</time_frame>
    <description>as measured by threshold target identification and night firing range</description>
  </primary_outcome>
  <primary_outcome>
    <measure>visual performance</measure>
    <time_frame>12 months postoperatively</time_frame>
    <description>as measured by contrast sensitivity</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">224</enrollment>
  <condition>Myopia</condition>
  <condition>Myopic Astigmatism</condition>
  <arm_group>
    <arm_group_label>Wavefront guided (WFG) PRK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>WFG LASIK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Wavefront optimized (WFO) PRK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>WFO LASIK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>WFG PRK</intervention_name>
    <arm_group_label>Wavefront guided (WFG) PRK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>WFG LASIK</intervention_name>
    <arm_group_label>WFG LASIK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>WFO PRK</intervention_name>
    <arm_group_label>Wavefront optimized (WFO) PRK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>WFO LASIK</intervention_name>
    <arm_group_label>WFO LASIK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Normal, healthy active adults with access to medical care at Walter Reed Health Care&#xD;
             System.&#xD;
&#xD;
          2. Male or female at least 21 years old at the time of the pre-operative examination, and&#xD;
             have signed an informed consent. The lower age limit of 21 years is intended to ensure&#xD;
             documentation of refractive stability.&#xD;
&#xD;
          3. Myopic spherical manifest refractive error from -1.00D up to -10.00D inclusive, with&#xD;
             no more than 4.00D of manifest cylinder refractive error.&#xD;
&#xD;
          4. Inclusion based on pre-op Central Corneal Thickness (CCT) will be assessed according&#xD;
             to Residual Stromal Bed Thickness&#xD;
&#xD;
          5. BSCVA of at least 20/20 in the study eye.&#xD;
&#xD;
          6. Soft contact lens users must have removed their lenses at least two weeks prior to&#xD;
             baseline and follow-up measurements.&#xD;
&#xD;
          7. Hard contact lens users (PMMA or rigid gas permeable lenses) must have removed their&#xD;
             lenses at least four weeks prior to baseline and follow-up measurements.&#xD;
&#xD;
          8. Refractive stability must be documented by previous refractions. Spherical and&#xD;
             cylindrical portion of the manifest refraction must not have varied by more than 0.50&#xD;
             diopters over the previous 12 months.&#xD;
&#xD;
          9. Exhibits strong motivation for keeping the follow-up visits.&#xD;
&#xD;
         10. Available for evaluation at Walter Reed during the 1 year follow-up period&#xD;
&#xD;
         11. If selected, willing and available to undergo testing at Ft. Belvoir during the study&#xD;
             period.&#xD;
&#xD;
         12. All service members must have a signed command authorization to receive government&#xD;
             sponsored refractive surgery. The signed command authorization will be included in the&#xD;
             original application.&#xD;
&#xD;
         13. Access to transportation to meet follow-up requirements.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Residual, recurrent or active ocular diseases or congenital corneal abnormalities in&#xD;
             either eye such as iritis, uveitis, keratoconjunctivitis sicca, herpetic keratitis,&#xD;
             vernal conjunctivitis, lagophthalmos, corneal scarring, anterior basement membrane&#xD;
             disease, recurrent erosions, glaucoma, previous steroid responder, occludable chamber&#xD;
             angles, visually significant cataracts.&#xD;
&#xD;
          2. History of any previous eye surgery or trauma, including previous refractive surgery.&#xD;
&#xD;
          3. Dry eye as reflected by Schirmer's test, subjective complaints or symptoms of dry eye,&#xD;
             findings during slit lamp exam that would be consistent with dry eye (e.g. superficial&#xD;
             punctuate keratitis).&#xD;
&#xD;
          4. Corneal thickness insufficient to allow the residual remaining stromal bed to be no&#xD;
             less than 300 microns in each eye. The residual stromal bed thickness will be&#xD;
             determined by subtracting both the LASIK flap thickness and depth of the ablation from&#xD;
             the total central corneal thickness measured by pachymetry.&#xD;
&#xD;
          5. Female subjects who are pregnant, breast-feeding or intend to become pregnant during&#xD;
             the study. This is standard of care exclusion for refractive surgery at the Walter&#xD;
             Reed Refractive Surgery Center because of the medications that are routinely given as&#xD;
             part of the procedures. Standard of care analgesia consists of medications (e.g.&#xD;
             narcotics) labeled as Pregnancy Category &quot;C&quot; by the FDA. Teratogenic effects are not&#xD;
             known, however, physical dependence in the neonate may occur if the mother is given&#xD;
             narcotics. Female subjects will be given a urine pregnancy test prior to participating&#xD;
             in the study to rule out pregnancy.&#xD;
&#xD;
          6. Concurrent topical or systemic medications that may impair healing, including&#xD;
             corticosteroids, antimetabolites, isotretinoin (Accutane), amiodarone hydrochloride&#xD;
             (Cordarone) and/or sumatripin (Imitrex).&#xD;
&#xD;
          7. Significant corneal neovascularization.&#xD;
&#xD;
          8. Progressive myopia or keratoconus.&#xD;
&#xD;
          9. Medical condition(s), which, in the judgment of the investigator, may impair healing,&#xD;
             including but not limited to: collagen vascular disease, autoimmune disease,&#xD;
             immunodeficiency diseases, and ocular herpes zoster or simplex.&#xD;
&#xD;
         10. Patients with known sensitivity or inappropriate responsiveness to any of the&#xD;
             medications used in the post-operative course.&#xD;
&#xD;
         11. Any physical or mental impairment which would preclude participation in any of the&#xD;
             examinations.&#xD;
&#xD;
         12. Inability to meet the mandated follow-up visit schedule for any reason such as duty&#xD;
             hours, impending deployments, or PCS.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kraig S Bower, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Wilmer Eye Institute, Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Walter Reed National Military Medical Center</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20889</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fort Belvoir Community Hospital</name>
      <address>
        <city>Fort Belvoir</city>
        <state>Virginia</state>
        <zip>22060</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>March 31, 2010</study_first_submitted>
  <study_first_submitted_qc>March 31, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2010</study_first_posted>
  <last_update_submitted>March 12, 2015</last_update_submitted>
  <last_update_submitted_qc>March 12, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 13, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Fort Belvoir Community Hospital</investigator_affiliation>
    <investigator_full_name>LTC Bruce Rivers</investigator_full_name>
    <investigator_title>Director, Warfighter Refractive Eye Surgery Program and Research Center at FT Belvoir</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Astigmatism</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

